Moreover, in IPAH patients, median plasma levels of BMP9 have been found to be significantly lower than those of control patients (209, 210, 212), with even lower plasmatic levels and plasma activity in patients carrying certain BMP9 mutations (209, 211). The gene discussed is GDF2; the disease is idiopathic pulmonary arterial hypertension.